Probiotic agents in critically ill patients

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Probiotics are living organisms which, when ingested in sufficient quantities, confer health benefits upon their host. In this era of increasing antimicrobial resistance, early probiotic studies describing reduced rates of nosocomial infections garnered significant interest, particularly from clinical investigators studying intensive care unit outcomes. Although our current knowledge base is fragmented and limited by various methodologic issues, metaanalysis has been a powerful tool to combine studies and more rigorously assess probiotics’ efficacy in various disease states. The resulting reports suggest that probiotics may reduce overall infection rates – including ventilatorassociated pneumonia and Clostridium difficile infections – in critically ill patients. However, definitive conclusions remain elusive, and rigorous multicenter trials are needed to confirm or refute the findings of these meta-analyses.

Original languageEnglish
Title of host publicationDiet and Nutrition in Critical Care
PublisherSpringer New York
Pages1017-1024
Number of pages8
ISBN (Electronic)9781461478362
ISBN (Print)9781461478379
DOIs
StatePublished - Jan 1 2015

Fingerprint

Probiotics
Critical Illness
Clostridium Infections
Intensive care units
Clostridium
Knowledge Bases
Clostridium difficile
Insurance Benefits
Cross Infection
Multicenter Studies
Intensive Care Units
Meta-Analysis
Pneumonia
Research Personnel
Health
Infection

All Science Journal Classification (ASJC) codes

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Morrow, L. E., Naveed, A., & Malesker, M. A. (2015). Probiotic agents in critically ill patients. In Diet and Nutrition in Critical Care (pp. 1017-1024). Springer New York. https://doi.org/10.1007/978-1-4614-7836-2_77

Probiotic agents in critically ill patients. / Morrow, Lee E.; Naveed, Albert; Malesker, Mark A.

Diet and Nutrition in Critical Care. Springer New York, 2015. p. 1017-1024.

Research output: Chapter in Book/Report/Conference proceedingChapter

Morrow, LE, Naveed, A & Malesker, MA 2015, Probiotic agents in critically ill patients. in Diet and Nutrition in Critical Care. Springer New York, pp. 1017-1024. https://doi.org/10.1007/978-1-4614-7836-2_77
Morrow LE, Naveed A, Malesker MA. Probiotic agents in critically ill patients. In Diet and Nutrition in Critical Care. Springer New York. 2015. p. 1017-1024 https://doi.org/10.1007/978-1-4614-7836-2_77
Morrow, Lee E. ; Naveed, Albert ; Malesker, Mark A. / Probiotic agents in critically ill patients. Diet and Nutrition in Critical Care. Springer New York, 2015. pp. 1017-1024
@inbook{322be1e375034b65b40971df6705065c,
title = "Probiotic agents in critically ill patients",
abstract = "Probiotics are living organisms which, when ingested in sufficient quantities, confer health benefits upon their host. In this era of increasing antimicrobial resistance, early probiotic studies describing reduced rates of nosocomial infections garnered significant interest, particularly from clinical investigators studying intensive care unit outcomes. Although our current knowledge base is fragmented and limited by various methodologic issues, metaanalysis has been a powerful tool to combine studies and more rigorously assess probiotics’ efficacy in various disease states. The resulting reports suggest that probiotics may reduce overall infection rates – including ventilatorassociated pneumonia and Clostridium difficile infections – in critically ill patients. However, definitive conclusions remain elusive, and rigorous multicenter trials are needed to confirm or refute the findings of these meta-analyses.",
author = "Morrow, {Lee E.} and Albert Naveed and Malesker, {Mark A.}",
year = "2015",
month = "1",
day = "1",
doi = "10.1007/978-1-4614-7836-2_77",
language = "English",
isbn = "9781461478379",
pages = "1017--1024",
booktitle = "Diet and Nutrition in Critical Care",
publisher = "Springer New York",
address = "United States",

}

TY - CHAP

T1 - Probiotic agents in critically ill patients

AU - Morrow, Lee E.

AU - Naveed, Albert

AU - Malesker, Mark A.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Probiotics are living organisms which, when ingested in sufficient quantities, confer health benefits upon their host. In this era of increasing antimicrobial resistance, early probiotic studies describing reduced rates of nosocomial infections garnered significant interest, particularly from clinical investigators studying intensive care unit outcomes. Although our current knowledge base is fragmented and limited by various methodologic issues, metaanalysis has been a powerful tool to combine studies and more rigorously assess probiotics’ efficacy in various disease states. The resulting reports suggest that probiotics may reduce overall infection rates – including ventilatorassociated pneumonia and Clostridium difficile infections – in critically ill patients. However, definitive conclusions remain elusive, and rigorous multicenter trials are needed to confirm or refute the findings of these meta-analyses.

AB - Probiotics are living organisms which, when ingested in sufficient quantities, confer health benefits upon their host. In this era of increasing antimicrobial resistance, early probiotic studies describing reduced rates of nosocomial infections garnered significant interest, particularly from clinical investigators studying intensive care unit outcomes. Although our current knowledge base is fragmented and limited by various methodologic issues, metaanalysis has been a powerful tool to combine studies and more rigorously assess probiotics’ efficacy in various disease states. The resulting reports suggest that probiotics may reduce overall infection rates – including ventilatorassociated pneumonia and Clostridium difficile infections – in critically ill patients. However, definitive conclusions remain elusive, and rigorous multicenter trials are needed to confirm or refute the findings of these meta-analyses.

UR - http://www.scopus.com/inward/record.url?scp=84945143957&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84945143957&partnerID=8YFLogxK

U2 - 10.1007/978-1-4614-7836-2_77

DO - 10.1007/978-1-4614-7836-2_77

M3 - Chapter

SN - 9781461478379

SP - 1017

EP - 1024

BT - Diet and Nutrition in Critical Care

PB - Springer New York

ER -